Few patients with migraine receive or are offered preventive therapy, leaving a significant treatment gap in this patient population, new research suggests. Investigators found that among patients with migraine who are eligible for preventive therapy, more than a third were…
Read More
Safety Profile for Novel CGRP Beats Standard of Care
Atogepant, an oral, small-molecule, calcitonin gene–related peptide receptor antagonist that’s been in development as a preventive treatment for chronic migraine, has been found to have fewer side effects and similar hepatic function profile to standard of care oral treatment after…
Read More
Why Do Some COVID-19 Tests Hurt So Much?
The one time I got tested for COVID-19, I wound up in the emergency room — but not because I tested positive. During the test, as the technician kept inching the swab deeper and deeper inside my nose, I felt…
Read More
Naprosyn SR
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NAPROSYN SR® pronounced nap-row-sin S-R contains the active ingredient naproxen Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about NAPROSYN SR…
Read More
Estalis Continuous
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ESTALIS® CONTINUOUS estradiol / norethisterone acetate (NETA) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about the menopause (the “change of…
Read More
Ralovera
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. RALOVERA® Medroxyprogesterone acetate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about RALOVERA.It does not contain all the available information.It does…
Read More
Mindfulness training does not reduce migraine frequency: study
(HealthDay)—Mindfulness-based stress reduction (MBSR) does not improve migraine frequency more than headache education, according to a study published online Dec. 14 in JAMA Internal Medicine. Rebecca Erwin Wells, M.D., M.P.H., from Wake Forest Baptist Health in Winston-Salem, North Carolina, and…
Read More
Rimegepant bests placebo for preventing migraine
(HealthDay)—Taken every other day, rimegepant demonstrates efficacy for the preventive treatment of migraine, according to a study published online Dec. 15 in The Lancet. Robert Croop, M.D., from Biohaven Pharmaceuticals in New Haven, Connecticut, and colleagues compared the efficacy of…
Read More
Using "pain sketches" to optimize migraine surgery outcomes
Credit: CC0 Public Domain “Can you draw me a picture of your headache?” may sound like an unusual question—but drawings of headache pain provide plastic surgeons with valuable information on which patients are more or less likely to benefit from…
Read More